1 | 2,2-bis(4-hydroxy-3-tert-butylphenyl)propane | - | - |
- |
- |
019 [4] 19, 86, 276, 299 💬 |
2 | Acetamide | 2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-n-(methylsulfonyl) acetamide [2] 2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-n-(methylsulfonyl) acetamide; Acetamide; | - |
- |
- |
086 [1] 86 💬 |
3 | Acetaminophen | Acetaminophen [9] Acetaminophen; Acetaminophen tab 650mg; Acetaminophen tablets; Acetaminophen/paracetamol; Multi-modal pain management [acetaminophen + gabapentin]; Oxycodone/acetaminophen; Paracetamol (acetaminophen); Tramadol /acetaminophen; Tramadol hydrochloride + acetaminophen; | [1] D00217 D00217 💬 |
[2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
003 [16] 3 , 6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
4 | Acetate | 11c-acetate [98] 11c-acetate; 2-(2-(2-amino-9h-purin-9-yl)ethyl)-1,3-propanediol diacetate ester; 20mg/0.5ml glatiramer acetate; 40 mg glatiramer acetate; 90 mg hydrocortisone acetate suppository with sephure suppository applicator; Abiraterone acetate; Acetate; Bazedoxifene acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Caspofungin acetate; Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Cosyntropin acetate; Cyclophosphamide/glatiramer acetate; Delmitide acetate; Depot leuprolide acetate 3.75 mg; Desmopressin acetate; Desmopressin acetate trihydrate; Device: cellulose acetate with petrolatum; Dichloroacetate; Dichloroacetate sodium; Dirucotide acetate; Edratide acetate; Etiprednol dicloacetate; Experimental glatiramer acetate; Flecainide acetate; Glatiramer acetate; Glatiramer acetate (copaxone®); Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (gtr); Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate [ga]; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Gonadorelin acetate and triptorelin acetate; Human interferon beta-1a and glatiramer acetate; Hydrocortisone acetate; Hydrocortisone sodium acetate; L-lysyl-d-prolyl-l-threonine acetate; L-lysyl-d-prolyl-lthreonine acetate, lyophilisate; Lanreotide acetate; Lapaquistat acetate and current lipid-lowering treatment; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate; Leuprorelin acetate 3.75mg injection; Loestrin (norethindrone acetate and ethinyl estradiol); Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Macimorelin acetate; Megestrol acetate; Megestrol acetate tablet; Methylprednisolone acetate; Nomegestrol acetate; Octreotide acetate; Oxaloacetate (oaa); Phosphate and betamethasone acetate, 2 ml.; Plovamer acetate; Plovamer acetate 0.5 milligram (mg); Plovamer acetate 10 mg; Plovamer acetate 20 mg; Plovamer acetate 3 mg; Prednisolone acetate; Prednisone acetate; Prednisone acetate tablets; Procedure: warm compress prior to injection of glatiramer acetate; Sodium acetate; Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate; Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Sotrastaurin (inn) acetate; Tetracosactide acetate; Tetracosactide hexaacetate; Tocopherol acetate; Tocopheryl acetate; Triptorelin acetate and gonadorelin acetate; Ulipristal acetate; Zinc acetate; Zinc acetate (20mg/d); Zinc acetate dihydrate; Zuretinol acetate; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; | - |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
5 | Acetazolamide | Acetazolamide [2] Acetazolamide; Acetazolamide sandoz 250; | [2] D00218 D00218
D01196 D01196 💬 |
[13] CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 |
Bile secretion [7] Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation |
013 [7] 13, 86, 90, 115, 155, 225, 230 💬 |
6 | Acetic acid C-11 | - | - |
- |
- |
013 [3] 13, 86, 88 💬 |
7 | Acetylsalicylic acid | Acetylsalicylic acid [2] Acetylsalicylic acid; Acetylsalicylic acid at 1st visit,; | [1] D00109 D00109 💬 |
[2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬 |
8 | Activated charcoal | - | [1] D03251 D03251 💬 |
- |
- |
006 [9] 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
9 | Albendazole | Albendazole [2] Albendazole; Albendazole (eskazole); | [1] D00134 D00134 💬 |
- |
- |
005 [11] 5 , 6 , 7 , 28, 51, 67, 86, 96, 97, 114, 127 💬 |
10 | Ambrisentan | Ambrisentan [11] Ambrisentan; Ambrisentan - high dose; Ambrisentan - low dose; Ambrisentan 5 mg; Ambrisentan 5 mg film-coated tablets; Ambrisentan 5mg film-coated tablets [marketed product]; Ambrisentan plus spironolactone; Ambrisentan tablet; Bosentan, ambrisentan; Tadalafil and ambrisentan upfront combination therapy; Volibris® (ambrisentan); | [1] D07077 D07077 💬 |
[1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [7] 51, 84, 85, 86, 88, 210, 211 💬 |
11 | Aminohippuric acid | - | [2] D01421 D01421
D06890 D06890 💬 |
- |
- |
049 [4] 49, 53, 67, 86 💬 |
12 | Ammonia | 13n-ammonia [4] 13n-ammonia; Ammonia; Radiation: cardiac pet imaging using f-18-fdg, n-13 ammonia( nh3); Radiation: pet/ct scan: two pet scans using 1. c-11 hed and 2. n-13 ammonia or rubidium-82; | [1] D02916 D02916 💬 |
- |
- |
006 [4] 6 , 17, 86, 88 💬 |
13 | Anakinra | Anakinra [8] Anakinra; Anakinra (kineret®); Anakinra (r-methuil-1ra); Anakinra / kineret; Anakinra and peg stnf-r1; Kineret® (anakinra); Kineret® or anakinra; Response to anakinra associated with methotrexate; | [1] D02934 D02934 💬 |
[2] IL1R1, IL1R2 💬 |
Amoebiasis [15] Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 [19] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬 |
14 | Anastrozole | Anastrozole [2] Anastrozole; Arimidex (anastrozole); | [1] D00960 D00960 💬 |
[1] CYP19A1 💬 |
Metabolic pathways [3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis |
078 [3] 78, 86, 193 💬 |
15 | Angiotensin II | Angiotensin ii [2] Angiotensin ii; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); | [2] D00150 D00150
D02014 D02014 💬 |
[2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [7] 17, 19, 46, 66, 86, 222, 224 💬 |
16 | Apabetalone | Apabetalone [1] Apabetalone; | [1] D11131 D11131 💬 |
- |
- |
086 [1] 86 💬 |
17 | Aspartame | - | [1] D02381 D02381 💬 |
[2] TAS1R2, TAS1R3 💬 |
Carbohydrate digestion and absorption [2] Carbohydrate digestion and absorption, Taste transduction |
006 [5] 6 , 13, 67, 86, 230 💬 |
18 | Aviptadil | Aviptadil [2] Aviptadil; Aviptadil, 66 microgram/ml; | - |
- |
- |
049 [4] 49, 51, 85, 86 💬 |
19 | Bardoxolone | Bardoxolone [9] Bardoxolone; Bardoxolone methyl; Bardoxolone methyl 10 mg; Bardoxolone methyl 15 mg; Bardoxolone methyl 20 mg; Bardoxolone methyl 5 mg; Bardoxolone methyl capsules; Bardoxolone methyl oral capsule; Bardoxolone methyl, cddo-me, cddo-methyl ester, nsc 713200, chemical name: oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester; | [1] D09584 D09584 💬 |
- |
- |
066 [7] 66, 67, 84, 85, 86, 218, 222 💬 |
20 | Bardoxolone methyl | Bardoxolone methyl [8] Bardoxolone methyl; Bardoxolone methyl 10 mg; Bardoxolone methyl 15 mg; Bardoxolone methyl 20 mg; Bardoxolone methyl 5 mg; Bardoxolone methyl capsules; Bardoxolone methyl oral capsule; Bardoxolone methyl, cddo-me, cddo-methyl ester, nsc 713200, chemical name: oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester; | [1] D09585 D09585 💬 |
- |
- |
066 [7] 66, 67, 84, 85, 86, 218, 222 💬 |
21 | Benzbromarone | Benzbromarone [1] Benzbromarone; | [1] D01056 D01056 💬 |
- |
- |
086 [1] 86 💬 |
22 | Beraprost | Beraprost [5] Beraprost; Beraprost sodium; Beraprost sodium 314d modified release tablets; Beraprost sodium modified release; Esuberaprost; | [1] D02720 D02720 💬 |
[1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
23 | Bevacizumab | Bevacizumab [5] Bevacizumab; Bevacizumab (avastin) and imatinib mesylate (gleevec); Bevacizumab (genitical recombination); Diagnostic test: pet-ct imaging with [89zr]-bevacizumab; Submucosal bevacizumab; | [1] D06409 D06409 💬 |
[1] VEGFA 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway |
013 [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬 |
24 | BIA | 200 mg bia 6-512 [26] 200 mg bia 6-512; 25 mg bia9 1067; 50 mg bia 9 1067; Bia; Bia 3-202; Bia 3-202 (200 mg); Bia 5-1058; Bia 6-512; Bia 6-512 100 mg; Bia 6-512 100 mg dose; Bia 6-512 200 mg dose; Bia 6-512 25 mg; Bia 6-512 25 mg dose; Bia 6-512 400 mg; Bia 6-512 50 mg dose; Bia 9-1067; Bia 9-1067 (test); Bia 9-1067 15 mg; Bia 9-1067 25 mg; Bia 9-1067 30 mg; Bia 9-1067 5 mg; Bia 9-1067 micronized; Bia 9-1067 non-micronized; Bia-5-1058; Other: tampa kinesiophobia scale, berg-balance test, international physical activity questionnaire-short form, falls efficacy scale; [14c]-bia 9-1067; | - |
- |
- |
006 [2] 6 , 86 💬 |
25 | Bisoprolol | Bisoprolol [2] Bisoprolol; Bisoprolol fumarate; | [2] D00634 D00634
D02342 D02342 💬 |
[1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
067 [3] 67, 86, 113 💬 |
26 | Bosentan | Bosentan [18] Bosentan; Bosentan (tracleer); Bosentan 125 mg; Bosentan 62.5 mg; Bosentan administration; Bosentan and sildenafil; Bosentan group; Bosentan monohidrato; Bosentan monohydrat; Bosentan monohydrate; Bosentan mylan; Bosentan, ambrisentan; Device: nirs after bosentan administration; Device: tcd after bosentan administration; Duo-therapy with sildenafil + bosentan; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Sildenafil 20mg and bosentan 62.5mg; Sildenafil singly or in association with bosentan; | [2] D01227 D01227
D07538 D07538 💬 |
[2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [11] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
27 | Capsaicin | Capsaicin [5] Capsaicin; Capsaicin challenge; Capsaicin vapor; Other: challenge agent: capsaicin; Qutenza (8% capsaicin); | [1] D00250 D00250 💬 |
[1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
002 [5] 2 , 6 , 19, 86, 226 💬 |
28 | Captopril | Captopril [2] Captopril; Spironolactone captopril carvedilol; | [1] D00251 D00251 💬 |
[1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
006 [8] 6 , 17, 46, 86, 96, 97, 107, 271 💬 |
29 | Carbon monoxide | Carbon monoxide [3] Carbon monoxide; Inhaled carbon monoxide; Other: carbon monoxide-bubbled mediums; | [1] D09706 D09706 💬 |
- |
- |
006 [7] 6 , 13, 53, 70, 85, 86, 298 💬 |
30 | Carvedilol | Carvedilol [2] Carvedilol; Spironolactone captopril carvedilol; | [2] D00255 D00255
D03415 D03415 💬 |
[5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 |
AMPK signaling pathway [12] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [5] 6 , 57, 86, 113, 210 💬 |
31 | Cetuximab | Cetuximab [1] Cetuximab; | [1] D03455 D03455 💬 |
[1] EGFR 💬 |
Adherens junction [46] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis |
034 [5] 34, 51, 86, 89, 331 💬 |
32 | Chlorhexidine | 2% chlorhexidine solution wipes [5] 2% chlorhexidine solution wipes; 4% chlorhexidine gluconate liquid skin cleanser; Chlorhexidine; Chlorhexidine gluconate; Chlorhexidine gluconate oral rinse; | [4] D00858 D00858
D01345 D01345
D03463 D03463
D07668 D07668 💬 |
- |
- |
086 [2] 86, 299 💬 |
33 | Cicletanine | Cicletanine [2] Cicletanine; Cicletanine hydrochloride; | [1] D03487 D03487 💬 |
- |
- |
086 [1] 86 💬 |
34 | Citrulline | 750 mg metformin and 7.5 g l-citrulline daily p.o. [5] 750 mg metformin and 7.5 g l-citrulline daily p.o.; Citrulline; L-citrulline and metformin & l-citrulline; L-citrulline malate; Metformin and metformin & l-citrulline; | [1] D07706 D07706 💬 |
- |
- |
086 [2] 86, 113 💬 |
35 | Clopidogrel | Clopidogrel [1] Clopidogrel; | [4] D00769 D00769
D07729 D07729
D10823 D10823
D10824 D10824 💬 |
[1] P2RY12 💬 |
Platelet activation [1] Platelet activation |
049 [2] 49, 86 💬 |
36 | Conivaptan | Conivaptan [2] Conivaptan; Spironolactone and conivaptan; | [2] D01236 D01236
D07748 D07748 💬 |
[2] AVPR1A, AVPR2 💬 |
Calcium signaling pathway [5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 [1] 86 💬 |
37 | CXA-10 | 150mg cxa-10 [3] 150mg cxa-10; 75mg cxa-10; Cxa-10; | - |
- |
- |
086 [2] 86, 222 💬 |
38 | D-glucose | 2-deoxy-2 [f-18] fluoro-2-d-glucose [3] 2-deoxy-2 [f-18] fluoro-2-d-glucose; D-glucose; [18f]fluoro-2-deoxy-2-d-glucose; | [1] D00009 D00009 💬 |
- |
- |
049 [3] 49, 86, 88 💬 |
39 | Dextrose, unspecified form | - | - |
- |
- |
002 [18] 2 , 6 , 13, 49, 50, 56, 60, 65, 70, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
40 | Dichloroacetic acid | - | - |
- |
- |
086 [1] 86 💬 |
41 | Diltiazem | Diltiazem [3] Diltiazem; Diltiazem gel 2%; Diltiazem hydrochloride; | [3] D00616 D00616
D03830 D03830
D07845 D07845 💬 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [3] 51, 58, 86 💬 |
42 | Dimethyl fumarate | Dimethyl fumarate [5] Dimethyl fumarate; Dimethyl fumarate (dmf); Dimethyl fumarate 240 mg; Dimethyl fumarate [dmf]; Tecifdera (dimethyl fumarate); | [1] D03846 D03846 💬 |
[1] KEAP1 💬 |
Fluid shear stress and atherosclerosis [4] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 [4] 13, 51, 86, 296 💬 |
43 | Diphenhydramine | Diphenhydramine [2] Diphenhydramine; Diphenhydramine hydrochloride; | [6] D00300 D00300
D00669 D00669
D02419 D02419
D03285 D03285
D03360 D03360
D03854 D03854 💬 |
[1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 [8] 11, 49, 51, 70, 86, 96, 222, 256 💬 |
44 | Elafin | Elafin [1] Elafin; | - |
- |
- |
086 [1] 86 💬 |
45 | Epicatechin | (+)- epicatechin [4] (+)- epicatechin; (+)-epicatechin; (-)-epicatechin; Epicatechin; | - |
- |
- |
086 [2] 86, 113 💬 |
46 | Epoprostenol | Act-385781a (actelion epoprostenol) [9] Act-385781a (actelion epoprostenol); Current marketed flolan (epoprostenol sodium); Epoprostenol; Epoprostenol for injection; Epoprostenol sodico; Epoprostenol sodium; Epoprostenol-actelion; Epoprostenolo per iniezione; New thermo stable formulation of epoprostenol sodium; | [2] D00106 D00106
D01337 D01337 💬 |
[1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
47 | Esomeprazole | Esomeprazole [3] Esomeprazole; Esomeprazole 20 mg; Nexium (esomeprazole magnesium); | [4] D01984 D01984
D04056 D04056
D07917 D07917
D09339 D09339 💬 |
[2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 [6] 13, 46, 86, 98, 298, 299 💬 |
48 | Famotidine | Famotidine [2] Famotidine; Famotidine 20 mg; | [1] D00318 D00318 💬 |
[1] HRH2 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
006 [4] 6 , 46, 86, 98 💬 |
49 | Ferric carboxymaltose | Ferric carboxymaltose [2] Ferric carboxymaltose; Intravenous administration of ferric carboxymaltose; | [1] D08920 D08920 💬 |
- |
- |
086 [4] 86, 96, 97, 299 💬 |
50 | Flunarizine | - | [2] D01303 D01303
D07971 D07971 💬 |
[3] CACNA1G, CACNA1H, CACNA1I 💬 |
Aldosterone synthesis and secretion [8] Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus |
058 [4] 58, 86, 149, 215 💬 |
51 | Fluoxetine | Amitriptyline, fluoxetine and tramadol alone (control group) [4] Amitriptyline, fluoxetine and tramadol alone (control group); Fluoxetine; Fluoxetine hydrochloride; Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group); | [2] D00326 D00326
D00823 D00823 💬 |
[1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [6] 13, 17, 78, 86, 179, 206 💬 |
52 | Fulvestrant | Fulvestrant [1] Fulvestrant; | [1] D01161 D01161 💬 |
[2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 [2] 49, 86 💬 |
53 | Gadobenic acid | - | [2] D04283 D04283
D08018 D08018 💬 |
- |
- |
013 [3] 13, 86, 88 💬 |
54 | Gadolinium | Device: magnetic resonance imaging (mri) with gadolinium enhancement [10] Device: magnetic resonance imaging (mri) with gadolinium enhancement; Device: magnetic resonance imaging (mri) without gadolinium enhancement; Diagnostic test: cardiac mri (gadolinium enhanced); Gadolinium; Gadolinium contrast; Gadolinium for abdomen; Gadolinium for lower back; Gadolinium-based contrast; Other: uspio mri - gadolinium mri; Standard gadolinium contrast; | - |
- |
- |
013 [6] 13, 34, 46, 58, 65, 86 💬 |
55 | Glycine | Flolan tm and glycine diluent [4] Flolan tm and glycine diluent; Flolan™ and glycine diluent; Glycine; Glycine buffer; | [1] D00011 D00011 💬 |
- |
- |
035 [5] 35, 60, 86, 226, 299 💬 |
56 | Gold | Gold [7] Gold; Gold nanocrystals; Mtx goldshield tablets; Other: comparator: cpet cycle ergometer (gold standard); Procedure: quantiferon-tb gold assay; Procedure: repair of cdh w/sis gold; Sodium aurothiomalate (intramuscular gold); | - |
- |
- |
002 [38] 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
57 | GSK2256098 | Gsk2256098 [2] Gsk2256098; [11c]-gsk2256098 500 mbq; | - |
- |
- |
086 [1] 86 💬 |
58 | Hydroxyurea | Hydroxyurea [1] Hydroxyurea; | [1] D00341 D00341 💬 |
[1] RRM2 💬 |
Drug metabolism - other enzymes [6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway |
003 [8] 3 , 13, 19, 20, 65, 85, 86, 284 💬 |
59 | Ifetroban | Ifetroban [2] Ifetroban; Oral ifetroban; | [1] D04500 D04500 💬 |
[1] TBXA2R 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation |
051 [3] 51, 86, 113 💬 |
60 | Iloprost | Aerosolized iloprost [23] Aerosolized iloprost; Commercial ventavis® (iloprost); Iloprost; Iloprost (5 µg); Iloprost (ventavis bayq6256); Iloprost (ventavis inhaled, bayq6256); Iloprost (ventavis, bayq 6256); Iloprost (ventavis, bayq6256); Iloprost (ventavis®); Iloprost inhalation solution (ventavis); Iloprost injection, for intravenous use; Iloprost low dose; Iloprost pd-15; Iloprost pd-6; Iloprost sale di trometamolo; Iloprost therapy up to 2 ng/kg x min; Iloprost trometamol; Iloprost,(ventavis, bayq6256); Inhaled iloprost (5 µg); Inhaled iloprost (ventavis, bayq6256); Other: iloprost (ventavis inhaled, bayq6256); Ventavis (iloprost, bayq6256); Ventavis(iloprost); | [1] D02721 D02721 💬 |
[1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [4] 51, 84, 85, 86 💬 |
61 | Imatinib | Bevacizumab (avastin) and imatinib mesylate (gleevec) [7] Bevacizumab (avastin) and imatinib mesylate (gleevec); Imatinib; Imatinib mesilate; Imatinib mesilato; Imatinib mesylate; Imatinib mesylate (gleevec); Imatinib mesylate 400mg capsule; | [2] D01441 D01441
D08066 D08066 💬 |
[3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
62 | Ipratropium | Bromure d'ipratropium [5] Bromure d'ipratropium; Ipratropium; Ipratropium bromide (drug); Nebulized combination ipratropium bromide with salbutamol; Nebulized ipratropium bromide; | [1] D02212 D02212 💬 |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [2] 6 , 86 💬 |
63 | Iron Dextran | Iron dextran [1] Iron dextran; | [1] D02141 D02141 💬 |
- |
- |
062 [4] 62, 86, 96, 97 💬 |
64 | Iron polymaltose | - | - |
- |
- |
086 [2] 86, 299 💬 |
65 | Lidocaine | 5% lidocaine/5 mg/ml 0.02% estradiol compound cream [11] 5% lidocaine/5 mg/ml 0.02% estradiol compound cream; Alkalinized lidocaine-heparin; Bladder instillation with heparin/ lidocaine; Heparin & alkalinized lidocaine bladder instillation; Lidocaine; Lidocaine 1% injectable solution; Lidocaine 2% without vessel constrictor; Lidocaine injection 2%; Lidocaine patch 5%; Lidocaine releasing intravesical system - liris®; Local anesthesia (lidocaine hydrochloride); | [3] D00358 D00358
D02086 D02086
D08127 D08127 💬 |
[5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [12] 6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬 |
66 | Lisuride | Continuous subcutaneous lisuride infusion [8] Continuous subcutaneous lisuride infusion; Lisuride; Lisuride hydrogenmaleate; Lisuride transdermal system; Lisuride tts; Lisuride tts 10cm²; Lisuride tts 20cm²; Transdihydrolisuride; | [2] D01462 D01462
D08132 D08132 💬 |
[3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [2] 6 , 86 💬 |
67 | Macitentan | Act-064992 (macitentan) [15] Act-064992 (macitentan); Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Fdc macitentan/tadalafil; Macitentan; Macitentan (act-064992); Macitentan 10 mg; Macitentan 10 mg tablet, once daily.; Macitentan 10mg; Macitentan 3 mg; Macitentan 37.5 mg; Macitentan 3mg; Macitentan 75 mg; Macitentan group; Macitentan tablets; Opsumit (macitentan); | [1] D10135 D10135 💬 |
[2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [5] 51, 85, 86, 88, 210 💬 |
68 | Medical air | Medical air [5] Medical air; Medical air (sham o2); Medical air vs oxygen; Other: medical air; Sham o2 (medical air); | - |
- |
- |
003 [8] 3 , 51, 58, 85, 86, 97, 193, 299 💬 |
69 | Metformin | 750 mg metformin and 7.5 g l-citrulline daily p.o. [21] 750 mg metformin and 7.5 g l-citrulline daily p.o.; Glucophage (metformin); L-citrulline and metformin & l-citrulline; Metformin; Metformin (generic); Metformin 500mg; Metformin and metformin & l-citrulline; Metformin hcl; Metformin hydrochloride; Metformin treatment; Metformin/cp-690,550; Metformina; Metformina - 500 30 compresse 500 mg; Metformine; Metformine arrow 500mg; Metformine hcl 500 pch; Metformine sandoz 850 mg filmomhulde tabletten; Other: metformin; Pioglitazone or metformin; Sitagliptin and metformin; [metformina]; | [2] D00944 D00944
D04966 D04966 💬 |
[2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 [21] 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
70 | Methamidophos | - | - |
- |
- |
002 [18] 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
71 | Methylprednisolone | Administration of rituximab and methylprednisolone [35] Administration of rituximab and methylprednisolone; Corticosteroid treatment (methylprednisolone or prednisolone); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Infliximab, methylprednisolone, methotrexate; Interferon-beta-1a (avonex) plus methylprednisolone; Intravenous (i.v.) methylprednisolone 1000 mg, total 9; Intravenous methylprednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methotrexate + methylprednisolone; Methylprednisolone; Methylprednisolone (drug); Methylprednisolone (mp); Methylprednisolone (mp) or prednisone (pred); Methylprednisolone (or other glucocorticoid); Methylprednisolone (solu-medrol); Methylprednisolone 1250 mg/24h x3 days; Methylprednisolone acetate; Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone mylan générique; Methylprednisolone or budesonide; Methylprednisolone or prednisolone; Methylprednisolone po; Methylprednisolone pulse; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Oral methylprednisolone 625 mg/24h x3 days; Prednisone (and methylprednisolone); Prednisone, methylprednisolone,cyclophosphamides; | [6] D00407 D00407
D00751 D00751
D00979 D00979
D05000 D05000
D05001 D05001
D05002 D05002 💬 |
[1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
72 | Morphine | Intraarticular morphine [7] Intraarticular morphine; Morphine; Morphine hexal; Morphine hydrochloride; Morphine pca; Morphine sulfate; Morphine sulphate in intrasite gel; | [3] D00842 D00842
D02271 D02271
D08233 D08233 💬 |
[1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 [5] 36, 46, 70, 85, 86 💬 |
73 | Moxifloxacin | Avelox- moxifloxacin [6] Avelox- moxifloxacin; Moxifloxacin; Moxifloxacin 400 mg; Moxifloxacin hydrochloride; Moxifloxacin infusion; Moxifloxacina cloridrato; | [2] D00874 D00874
D08237 D08237 💬 |
- |
- |
002 [8] 2 , 6 , 46, 49, 85, 86, 240, 299 💬 |
74 | Nicardipine | Nicardipine [1] Nicardipine; | [2] D00617 D00617
D08270 D08270 💬 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
070 [2] 70, 86 💬 |
75 | Nilotinib | Cohort 1:nilotinib oral capsules (150mg or 300mg) [9] Cohort 1:nilotinib oral capsules (150mg or 300mg); Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1); Nilotinib; Nilotinib (tasigna); Nilotinib 150 mg; Nilotinib 150mg oral capsule [tasigna]; Nilotinib 300mg oral capsule [tasigna]; Nilotinib 50 mg; Nilotinib hydrochloride monohydrate; | [1] D08953 D08953 💬 |
[4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [5] 6 , 8 , 34, 51, 86 💬 |
76 | Nitric Oxide | Inhaled nitric oxide [14] Inhaled nitric oxide; Inhaled nitric oxide & inopulse delivery; Inhaled nitric oxide - 30 mcg/kg ibw/hr; Inhaled nitric oxide 5,10,15 mcg/kg ibw/hr; Inhaled nitric oxide 75 mcg/kg ibw/hr; Nitric oxide; Nitric oxide 160 ppm; Nitric oxide for inhalation; Nitric oxide generated by the geno nitrosyl delivery system; Nitric oxide plus oxygen; Nitric oxide supplement; Other: oral nitric oxide testing; Procedure: exhaled nitric oxide; Procedure: exhaled nitric oxide assessment; | [1] D00074 D00074 💬 |
- |
- |
046 [8] 46, 85, 86, 98, 210, 251, 294, 299 💬 |
77 | Nitrite | 120 mg sodium nitrite inhalation solution [9] 120 mg sodium nitrite inhalation solution; 15 mg sodium nitrite inhalation solution; 25% mtd sodium nitrite inhalation solution; 45 mg sodium nitrite inhalation solution; 90 mg sodium nitrite inhalation solution; Air001 (sodium nitrite inhalation solution); Nitrite; Sodium nitrite; Sodium nitrite inhalation solution; | - |
- |
- |
086 [2] 86, 299 💬 |
78 | Olaparib | Olaparib [1] Olaparib; | [1] D09730 D09730 💬 |
[2] PARP1, PARP2 💬 |
Apoptosis [5] Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis |
086 [2] 86, 285 💬 |
79 | Oxygen | Behavioral: respiratory and exercise therapy with supplemental oxygen [39] Behavioral: respiratory and exercise therapy with supplemental oxygen; Combination product: hyperbaric oxygen therapy-; Continuous oxygen; Device: auto-titrating oxygen system; Device: capacity of muscular oxygen extraction; Device: high flow nasal oxygen cannula; Device: hyperbaric oxygen; Device: intermittent exposure to oxygen via oro-nasal mask; Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation; Device: oxygen; Device: oxygen saturation; Device: standard oxygen therapy/ra; Diagnostic test: maximum oxygen uptake; Helium / oxygen mixed gas inhalation therapy; Medical air vs oxygen; Medical grade oxygen; Nitric oxide plus oxygen; Other: 60% oxygen; Other: air - oxygen; Other: hyperbaric oxygen; Other: hyperbaric oxygen therapy; Other: muscle oxygenation; Other: optional blood-oxygen-level dependent functionalmri; Other: oxygen; Other: oxygen (2liter/min); Other: oxygen (4liter/min); Other: oxygen - air; Other: oxygen supplementation; Oxygen; Oxygen 40 %; Oxygen supplementation; Oxygen, liquid; Perfluorinated gas/oxygen mixture; Procedure: hyperbaric oxygen; Procedure: hyperbaric oxygen therapy; Procedure: long term oxygen therapy; Procedure: oxygen flow at the optic nerve head measurement; Procedure: supplemental oxygen via a mask; Standard analgesia use [oxygen]; | [1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
80 | PF-00489791 | Pf-00489791 [1] Pf-00489791; | - |
- |
- |
086 [1] 86 💬 |
81 | Pioglitazone | Actos (pioglitazone) [6] Actos (pioglitazone); Pioglitazone; Pioglitazone 15 mg; Pioglitazone and tretinoin; Pioglitazone or metformin; Tretinoin and pioglitazone hcl; | [2] D00945 D00945
D08378 D08378 💬 |
[1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
82 | Placental Mesenchymal Stem Cells | Placental mesenchymal stem cells [2] Placental mesenchymal stem cells; Placental mesenchymal stem cells seeded on a commercially available dural graft extracellular matrix; | - |
- |
- |
086 [2] 86, 118 💬 |
83 | Prasterone | Prasterone [2] Prasterone; Prasterone (gl701); | [1] D08409 D08409 💬 |
[3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 [6] 49, 53, 83, 86, 96, 113 💬 |
84 | Prednisone | 0 mg prednisone [73] 0 mg prednisone; 5 mg prednisone; 5-aminosalicylic acid(5-asa) and/or prednisone; Adalimumab, plus prednisone; Azathioprine/prednisone; Chinese herb prescription granule plus prednisone; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Cyclophosphamide-prednisone-azathioprine; Enalapril valsartan methylprednisone; Glucocorticoid (prednisone or prednisolone); Granulocyte-colony stimulating factor (g-csf) and prednisone; Hormone (prednisone); Hydroxychloroquine + prednisone; Ir prednisone; Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Methylprednisone; Mr prednisone; Mycophenolate mofetil plus lower dose of prednisone; Oral prednisone; Oral prednisone 5mg; Other: prednisone; Over encapsulated prednisone; Prednisolone/prednisone; Prednisone; Prednisone (and methylprednisolone); Prednisone + inhibace/cozaar; Prednisone - azathioprine; Prednisone 0,5 mg/kg orally on alternate days; Prednisone 1 mg; Prednisone 15 mg; Prednisone 2 mg; Prednisone 3 mg; Prednisone 4 mg; Prednisone 5 mg; Prednisone 5 mg tablets; Prednisone 7.5 mg; Prednisone acetate; Prednisone acetate tablets; Prednisone alone; Prednisone and belimumab; Prednisone and cyclophosphamide; Prednisone and mycophenolate mofetil; Prednisone and ustekinumab treatment; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone capsules; Prednisone discontinuation; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Prednisone, ciclosporin and mycophenolate mofetil; Prednisone, cyclophosphamide; Prednisone, fk506, mmf; Prednisone, low dose rituximab; Prednisone, methylprednisolone,cyclophosphamides; Prednisone/prednisolone; Procedure: thymectomy plus prednisone; Rayos (delayed-release prednisone); Sotatercept with prednisone boost; Tacrolimus combined with prednisone; Thalidomide, cyclophosphamide and prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Ursodeoxycholic acid+low dose glucocorticoid(prednisone); | [1] D00473 D00473 💬 |
[1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
85 | Ralinepag | Ralinepag [1] Ralinepag; | [1] D10725 D10725 💬 |
[1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
86 | Ranolazine | Ranolazine [7] Ranolazine; Ranolazine 1000 mg; Ranolazine 1000 mg pr tablets; Ranolazine 500 mg; Ranolazine 500 mg pr tablets; Ranolazine 750 mg pr tablets; Ranolazine pr (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die; | [2] D05700 D05700
D05701 D05701 💬 |
- |
- |
002 [6] 2 , 58, 86, 96, 113, 114 💬 |
87 | Recombinant Human Angiotensin-Converting Enzyme 2 | Recombinant human angiotensin-converting enzyme 2 [2] Recombinant human angiotensin-converting enzyme 2; Recombinant human angiotensin-converting enzyme 2 (ace2), apn01; | - |
- |
- |
086 [1] 86 💬 |
88 | Rifampicin | Rifampicin [1] Rifampicin; | [1] D00211 D00211 💬 |
- |
- |
006 [8] 6 , 13, 17, 46, 84, 86, 93, 299 💬 |
89 | Riociguat | Adempas (riociguat, bay63-2521) [14] Adempas (riociguat, bay63-2521); Riociguat; Riociguat (adempas, bay63-2521); Riociguat (bay63-2521); Riociguat coated tablet 0.5 mg; Riociguat coated tablet 1.0 mg; Riociguat coated tablet 1.5 mg; Riociguat coated tablet 2.0 mg; Riociguat coated tablet 2.5 m; Riociguat coated tablet 2.5 mg; Riociguat granules 0.3% for oral application; Riociguat oral product; Riociguat oral tablet; Riociguat pill; | [1] D09572 D09572 💬 |
[3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [6] 51, 84, 86, 88, 225, 299 💬 |
90 | Ritonavir | Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis) [10] Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis); Atazanavir/ritonavir; Lopinavir/ritonavir; Lopinavir/ritonavir + nevirapine; Lopinavir/ritonavir + zidovudine + lamivudine; Monotherapy (lopinavir/ritonavir); Monotherapy (lopinavir/ritonavir) + abc/3tc; Ritonavir; Ritonavir (norvir); Saquinavir and ritonavir; | [1] D00427 D00427 💬 |
- |
- |
002 [3] 2 , 86, 265 💬 |
91 | Rituximab | Abatacept, rituximab or tocilizumab [67] Abatacept, rituximab or tocilizumab; Abp 798 - biosimilar to rituximab; Abp 798 biosimilar to rituximab; Administration of rituximab and methylprednisolone; Alemtuzumab and rituximab; Alemtuzumab, rituximab; Bendamustine, rituximab; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Combined plasma exchange (pex), rituximab, and corticosteroids; Dexamethasone and rituximab; Double-blind rituximab; Dr. reddy’s rituximab (drl_ri) 100mg; Dr. reddy’s rituximab (drl_ri) 500mg; Eltrombopag combining rituximab; Etanercepet, rituximab, abatacept, tocilizumab, sarilumab; Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab); Gp2013 - a proposed biosimilar rituximab; Idec-c2b8 (rituximab); Immunosuppressive treatment (eg, rituximab); Individualized dose of rituximab; Intravenous rituximab; Mabthera (rituximab); Mabthera or biosimilar rituximab product; Mabthera® (rituximab); Originator rituximab - rituxan ® or mabthera ®; Prednisone, low dose rituximab; Rhtpo in combination with rituximab; Rituxan (inn: rituximab), brand name in the united states; Rituxan (inn: rituximab), brand name in the us; Rituxan (rituximab); Rituxan® (rituximab); Rituximab; Rituximab (anti-cd20); Rituximab (arm a); Rituximab (arm b); Rituximab (eu); Rituximab (genetical recombination); Rituximab (mabthera® or rituxan®).; Rituximab (mabthera®); Rituximab (rituxan); Rituximab (rtx) and azathioprine (aza); Rituximab (us); Rituximab - mabthera; Rituximab 1g iv; Rituximab [mabthera/rituxan]; Rituximab [mabthera]; Rituximab and cyclophosphamide iv; Rituximab combined with omalizumab; Rituximab infusion; Rituximab it; Rituximab iv; Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml; Rituximab mabthera; Rituximab or rituximab hyaluronidase human; Rituximab, mabthera; Rituximab, mtx, folic acid; Rituximab, observational study amon patients with active ra; Rituximab-eu+ rituximab-pfizer x 2 courses; Rituximab-pfizer; Rituximab-pfizer (pf-05280586) x 3 courses; Rituximab-us + rituximab-pfizer x 2 courses; Rituximab/ mabthera; Sait101 (proposed rituximab biosimilar); Sait101 (rituximab biosimilar); Standard dose of rituximab; The standard steroid treatment, plasma exchange and rituximab; [rituximab]; | [1] D02994 D02994 💬 |
[1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
92 | Rubidium | Radiation: pet/ct scan: two pet scans using 1. c-11 hed and 2. n-13 ammonia or rubidium-82 [3] Radiation: pet/ct scan: two pet scans using 1. c-11 hed and 2. n-13 ammonia or rubidium-82; Radiation: rubidium pet; Rubidium; | - |
- |
- |
084 [2] 84, 86 💬 |
93 | Salbutamol | Nebulized combination ipratropium bromide with salbutamol [9] Nebulized combination ipratropium bromide with salbutamol; Other: salbutamol nebulisation and with cpap; R-salbutamol; R-salbutamol sulphate; Salbutamol; Salbutamol 4mg tablet; Salbutamol sulfate; Salbutamol sulfate ph. eur.; Salbutamol wzf 4 mg; | [1] D02147 D02147 💬 |
[1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 [14] 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬 |
94 | Sapropterin | Kuvan® (sapropterin dihydrochloride) [11] Kuvan® (sapropterin dihydrochloride); Sapropterin; Sapropterin (kuvan); Sapropterin dihydrochloride; Sapropterin dihydrochloride (6r-bh4); Sapropterin dihydrochloride, 6r-bh4, tetrahydrobiopterin; Sapropterin dihydrocholoride; Sapropterin hydrochloride; Sapropterin, sapropterin dihydrochloride; Sapropterin, sapropterin hydrochloride; Sapropterindihydrochloride; | [1] D08505 D08505 💬 |
- |
- |
051 [5] 51, 86, 124, 240, 299 💬 |
95 | Saquinavir | Saquinavir [2] Saquinavir; Saquinavir and ritonavir; | [2] D00429 D00429
D01160 D01160 💬 |
- |
- |
086 [2] 86, 265 💬 |
96 | Selexipag | I.v. selexipag [5] I.v. selexipag; Oral selexipag (uptravi); Selexipag; Selexipag (uptravi); Selexipag, act-293987 (ns-304); | [1] D09994 D09994 💬 |
[1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [5] 51, 70, 84, 86, 88 💬 |
97 | Selonsertib | Selonsertib [1] Selonsertib; | [1] D10988 D10988 💬 |
[1] MAP3K5 💬 |
Alzheimer disease [17] Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Fluid shear stress and atherosclerosis, Huntington disease, MAPK signaling pathway, Neurotrophin signaling pathway, Non-alcoholic fatty liver disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Protein processing in endoplasmic reticulum, Sphingolipid signaling pathway, Spinocerebellar ataxia, TNF signaling pathway, Thermogenesis, Tight junction |
086 [1] 86 💬 |
98 | Serine | D-serine [4] D-serine; D-serine (~2g/day); L-serine; Serine; | [1] D00016 D00016 💬 |
- |
- |
002 [3] 2 , 6 , 86 💬 |
99 | Sildenafil | 20 mg sildenafil citrate by mouth [32] 20 mg sildenafil citrate by mouth; 5% sildenafil cream; Access program - sildenafil citrate, viagra, revatio; Bosentan and sildenafil; Duo-therapy with sildenafil + bosentan; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); G04be03- sildenafil - sildenafil (citrato); Mono-therapy with sildenafil; Oral sildenafil; Other: standard of care sildenafil; Sildenafil; Sildenafil (50 mg); Sildenafil (acute-1 hour); Sildenafil (as citrate); Sildenafil (revatio); Sildenafil (revatio) 20 mg tid; Sildenafil (subchronic-4 weeks); Sildenafil 20 mg tablets; Sildenafil 20mg; Sildenafil 20mg and bosentan 62.5mg; Sildenafil 40mg oral capsule; Sildenafil and losartan; Sildenafil by injection; Sildenafil citrate; Sildenafil citrate (uk-92,480); Sildenafil filmtabletten; Sildenafil singly or in association with bosentan; Sildenafil therapy; Sildenafilo; Sitaxsentan and sildenafil; Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth; Tadalafil and sildenafil; | [2] D02229 D02229
D08514 D08514 💬 |
[1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
100 | Simvastatin | Encapsulated simvastatin tablets [21] Encapsulated simvastatin tablets; Ezetimibe+simvastatin drug combination; Other: simvastatin; Simvastatin; Simvastatin 20 mg; Simvastatin 20mg/5ml oral suspension; Simvastatin 40 mg; Simvastatin 40 mg film-coated tablets; Simvastatin 40 mg tablets; Simvastatin 40mg; Simvastatin alternova; Simvastatin in relapsing remitting multiple sclerosis; Simvastatin susp.; Simvastatin treatment for 28 days; Simvastatin-ratiopharm; Simvastatin-ratiopharm®; Simvastatina; Simvastatina sandoz 40 mg comprimidos recubiertos con película efg; Simvastatine; Simvastatine sandoz 40 mg filmomhulde tabletten; Simvastatine sandoz 40mg deelbare filmomhulde tabletten; | [1] D00434 D00434 💬 |
[1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [21] 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
101 | Sirolimus | Rapamycin, sirolimus [22] Rapamycin, sirolimus; Sirolimus; Sirolimus (formerly known as rapamycin); Sirolimus (study drug)+ace inhibitor + statin; Sirolimus 0,1% crème; Sirolimus 0.2%; Sirolimus 0.4%; Sirolimus 1mg/ml; Sirolimus 2 mg; Sirolimus 2%; Sirolimus and hydroxychloroquine 200 mg; Sirolimus and hydroxychloroquine 400 mg; Sirolimus ointment; Sirolimus oral liquid product 1mg/ml; Sirolimus oral product; Sirolimus, 2%; Skincerity plus sirolimus/rapamycin; Skinercity plus sirolimus/rapamycin; Tavt-18 (sirolimus); Temsirolimus; Temsirolimus tablets; Topical 0.1% sirolimus; | [1] D00753 D00753 💬 |
[1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 [40] 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
102 | Sitaxentan | Sitaxentan [2] Sitaxentan; Sitaxentan sodium; | [1] D07171 D07171 💬 |
[1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
103 | Sorafenib | Nexavar (bay 43-9006) (sorafenib) [3] Nexavar (bay 43-9006) (sorafenib); Sorafenib; Sorafenib (as tosylate); | [2] D06272 D06272
D08524 D08524 💬 |
[8] BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 |
Acute myeloid leukemia [87] Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway |
034 [2] 34, 86 💬 |
104 | Sotatercept | Sotatercept [2] Sotatercept; Sotatercept with prednisone boost; | [1] D09670 D09670 💬 |
[1] ACVR2A 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway |
086 [2] 86, 284 💬 |
105 | Spironolactone | Ambrisentan plus spironolactone [5] Ambrisentan plus spironolactone; Spironolactone; Spironolactone (drug); Spironolactone and conivaptan; Spironolactone captopril carvedilol; | [1] D00443 D00443 💬 |
[1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
058 [7] 58, 67, 86, 113, 210, 218, 225 💬 |
106 | Sulfasalazine | Leflunomide-sulfasalazine-hydroxychloroquine [6] Leflunomide-sulfasalazine-hydroxychloroquine; Methotrexate plus sulfasalazine; Methotrexate-sulfasalazine-hydroxychloroquine; Nsaids and sulfasalazine; Sulfasalazine; Sulfasalazine, ssz; | [1] D00448 D00448 💬 |
- |
- |
046 [4] 46, 86, 94, 271 💬 |
107 | Sulfate ion | - | - |
- |
- |
002 [25] 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
108 | Tadalafil | Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan) [13] Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Fdc macitentan/tadalafil; Tadalafil; Tadalafil 20 mg; Tadalafil 20 mg film-coated tablets; Tadalafil 40 mg; Tadalafil and ambrisentan upfront combination therapy; Tadalafil and sildenafil; Tadalafil citrate; Tadalafil oral suspension; Tadalafil, placebo; Tadalafil- tablet or oral suspension; Tadalafilo; | [1] D02008 D02008 💬 |
[1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [7] 6 , 51, 75, 84, 86, 113, 210 💬 |
109 | Tamoxifen | Tamoxifen [4] Tamoxifen; Tamoxifen 20mg hexal® filmtabletten; Tamoxifen 40 mg daily for one year; Tamoxifen citrate; | [2] D00966 D00966
D08559 D08559 💬 |
[2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
002 [4] 2 , 86, 113, 227 💬 |
110 | Terguride | Terguride [4] Terguride; Terguride 0,5mg tablet; Terguride 0.5 mg tablet; Terguride hydrogenmaleate; | [1] D01348 D01348 💬 |
[2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
051 [2] 51, 86 💬 |
111 | Tezosentan | Tezosentan [1] Tezosentan; | - |
- |
- |
086 [1] 86 💬 |
112 | Threonine | L-lysyl-d-prolyl-l-threonine acetate [5] L-lysyl-d-prolyl-l-threonine acetate; L-lysyl-d-prolyl-lthreonine acetate, lyophilisate; Lysine-d-proline-threonine; Other: threonine; Threonine; | [1] D00041 D00041 💬 |
- |
- |
086 [3] 86, 96, 97 💬 |
113 | Thrombin | Diagnostic test: endogenous thrombin potential [2] Diagnostic test: endogenous thrombin potential; Thrombin; | [1] D00090 D00090 💬 |
- |
- |
086 [2] 86, 88 💬 |
114 | Tocilizumab | Abatacept, rituximab or tocilizumab [39] Abatacept, rituximab or tocilizumab; Adalimuab, etanercept, tocilizumab, or abatacept; Corticoids+ tocilizumab 8mg/kg/4 weeks; Decrease tocilizumab, abatacept; Etanercepet, rituximab, abatacept, tocilizumab, sarilumab; Inn-tocilizumab; Intra-articular tocilizumab; Mra (tocilizumab); Mra(tocilizumab); Subcutaneous tocilizumab; Tocilizumab; Tocilizumab (actemra or roactemra); Tocilizumab (actemra); Tocilizumab (actemra®); Tocilizumab (mra-sc); Tocilizumab (tcz); Tocilizumab + glucocorticoids (gcs); Tocilizumab + methotrexate(mtx); Tocilizumab 162 mg; Tocilizumab 162mg/0.9ml jeringa sc; Tocilizumab 162mg/0.9ml sc pfs sc; Tocilizumab 162mg/0.9ml syringe sc; Tocilizumab [roactemra/actemra]; Tocilizumab [roactemra]; Tocilizumab and iv steroids combination; Tocilizumab infusion roacemtra (eu); Tocilizumab injection; Tocilizumab iv; Tocilizumab plus methotrexate; Tocilizumab prefilled syringe; Tocilizumab roche; Tocilizumab sc; Tocilizumab sc 162 mg/0.9 ml disposable auto-injector (ai); Tocilizumab sc 162 mg/0.9 ml pre-filled syringe with safety device (pfs); Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs); Tocilizumab treatment; Tocilizumab+methotrexate(mtx); Tocilizumab, abatacept; Tocilizumabum; | [1] D02596 D02596 💬 |
[1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 [18] 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
115 | Treprostinil | Combination product: implantable system for remodulin (treprostinil) [39] Combination product: implantable system for remodulin (treprostinil); Combination product: treprostinil via implanted pump; Cutaneous iontophoresis of treprostinil; Dietanolamina de treprostinilo; Eutonic treprostinil solution; Hypotonictreprostinil solution; Inhaled dry powder treprostinil (liq861); Inhaled treprostinil; Intravenous treprostinil; Intravenous/subcutaneous treprostinil; Iontophoresis of treprostinil; L606 (liposomal treprostinil) inhalation solution 51ug; Liq861 inhaled treprostinil; Oral treprostinil; Oral treprostinil (ut-15c) sustained release tablets; Parenteral remodulin (treprostinil) injection; Rapid dose titration group of subcutaneous treprostinil; Remodulin (treprostinil sodium); Remodulin® (treprostinil) 1 mg/ml solution for infusion; Remodulin® (treprostinil) 10 mg/ml solution for infusion; Remodulin® (treprostinil) 2.5 mg/ml solution for infusion; Remodulin® (treprostinil) 5 mg/ml solution for infusion; Slow dose titration group of subcutaneous treprostinil; Subcutaneous treprostinil; Treprostinil; Treprostinil dietanolamina; Treprostinil diethanolamine; Treprostinil diolamine; Treprostinil inhalation powder; Treprostinil inhalations; Treprostinil injectable product; Treprostinil sodium; Treprostinil sodium for inhalation; Treprostinil sodium solution for inhalation; Treprostinil sodium, ut-15; Treprostinil, ut-15, lrx-15, 15au81, bw a15au, u-62, 840; Treprostinilo; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine); | [1] D06213 D06213 💬 |
[1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [6] 51, 84, 85, 86, 88, 210 💬 |
116 | Trimetazidine | Trimetazidine [3] Trimetazidine; Trimetazidine dihydrochloride; Trimetazidine dihydrochloride 20mg; | [2] D01606 D01606
D08642 D08642 💬 |
- |
- |
058 [2] 58, 86 💬 |
117 | Tyrosine | L-tyrosine [2] L-tyrosine; Tyrosine; | [1] D00022 D00022 💬 |
- |
- |
006 [5] 6 , 75, 86, 111, 298 💬 |
118 | Ubenimex | Ubenimex [1] Ubenimex; | [1] D00087 D00087 💬 |
[1] ANPEP 💬 |
Glutathione metabolism [4] Glutathione metabolism, Hematopoietic cell lineage, Metabolic pathways, Renin-angiotensin system |
086 [1] 86 💬 |
119 | Ubidecarenone | - | [1] D01065 D01065 💬 |
- |
- |
002 [13] 2 , 5 , 6 , 8 , 10, 18, 46, 57, 86, 113, 193, 214, 215 💬 |
120 | Udenafil | Udenafil [1] Udenafil; | [1] D10027 D10027 💬 |
[1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [2] 86, 210 💬 |
121 | Vardenafil | Rt234 - vardenafil inhalation powder [5] Rt234 - vardenafil inhalation powder; Vardenafil; Vardenafil (hidrocloride); Vardenafilo; Vardenafilo hidrocloruro; | [3] D02731 D02731
D03260 D03260
D08668 D08668 💬 |
[1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 [3] 13, 86, 299 💬 |
122 | Zamicastat | Zamicastat [1] Zamicastat; | - |
- |
- |
086 [1] 86 💬 |